Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients-Reference-Cited by-同舟云学术

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients

Published:2016-07-25 Issue:1 Volume:65 Page:54-64
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Leung Jonathan Chung‐Fai¹,Loong Thomson Chi‐Wang¹,Wei Jeremy Lok¹,Wong Grace Lai‐Hung¹²,Chan Anthony Wing‐Hung³,Choi Paul Cheung‐Lung³,Shu Sally She‐Ting¹²,Chim Angel Mei‐Ling¹²,Chan Henry Lik‐Yuen¹²,Wong Vincent Wai‐Sun¹²

Affiliation:

1. Department of Medicine and TherapeuticsThe Chinese University of Hong KongShatin Hong Kong

2. State Key Laboratory of Digestive DiseaseThe Chinese University of Hong KongShatin Hong Kong

3. Department of Anatomical and Cellular PathologyThe Chinese University of Hong KongShatin Hong Kong

Funder

Chinese University of Hong Kong

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.28697

Reference38 articles.

1. Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy

2. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

3. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009

4. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

5. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease;Journal of Clinical and Experimental Hepatology;2025-01

2. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

3. Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2024-10

4. Characteristics of intestinal flora in nonobese nonalcoholic fatty liver disease patients and the impact of ursodeoxycholic acid treatment on these features;Lipids;2024-09-09

5. Therapeutic evaluation of the novel FGF21 analogue DC2303 for metabolic dysfunction-associated steatohepatitis;2024-08-26